Compare ATLO & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATLO | RPID |
|---|---|---|
| Founded | 1903 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.3M | 178.6M |
| IPO Year | N/A | 2021 |
| Metric | ATLO | RPID |
|---|---|---|
| Price | $23.90 | $3.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 19.8K | ★ 110.4K |
| Earning Date | 01-23-2026 | 11-07-2025 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | ★ 82.57 | N/A |
| EPS | ★ 1.80 | N/A |
| Revenue | ★ $60,568,000.00 | $30,523,000.00 |
| Revenue This Year | N/A | $19.36 |
| Revenue Next Year | N/A | $21.48 |
| P/E Ratio | $13.22 | ★ N/A |
| Revenue Growth | ★ 18.60 | 16.63 |
| 52 Week Low | $15.75 | $0.87 |
| 52 Week High | $24.11 | $4.50 |
| Indicator | ATLO | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 81.63 | 45.96 |
| Support Level | $21.86 | $3.78 |
| Resistance Level | $22.30 | $4.07 |
| Average True Range (ATR) | 0.40 | 0.21 |
| MACD | 0.21 | -0.08 |
| Stochastic Oscillator | 90.91 | 20.93 |
Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.